关注
Hanmant goykar
Hanmant goykar
未知所在单位机构
没有经过验证的电子邮件地址
标题
引用次数
引用次数
年份
Reactive oxygen nano-generators for cancer therapy
D Kalyane, D Choudhary, S Polaka, H Goykar, T Karanwad, K Rajpoot, ...
Progress in Materials Science 130, 100974, 2022
262022
An understanding of mitochondria and its role in targeting nanocarriers for diagnosis and treatment of cancer
D Choudhary, H Goykar, T Karanwad, S Kannaujia, V Gadekar, M Misra
Asian Journal of Pharmaceutical Sciences 16 (4), 397-418, 2021
172021
Prodrug design for improving the biopharmaceutical properties of therapeutic drugs
D Choudhary, H Goykar, D Kalyane, N Sreeharsha, RK Tekade
The Future of Pharmaceutical Product Development and Research, 179-226, 2020
132020
Exosomes in multidrug-resistant cancer
D Kalyane, D Choudhary, S Polaka, H Goykar, N Anup, V Tambe, K Kalia, ...
Current Opinion in Pharmacology 54, 109-120, 2020
62020
Chronopharmacokinetics
D Choudhary, H Goykar, K Rajpoot, RK Tekade
Biopharmaceutics and Pharmacokinetics Considerations, 163-194, 2021
42021
Dose, dosage regimen, and dose adjustment in organ failure
D Choudhary, H Goykar, D Kalyane, N Desai, RK Tekade
Biopharmaceutics and pharmacokinetics considerations, 29-82, 2021
42021
系统目前无法执行此操作,请稍后再试。
文章 1–6